These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24474012)

  • 1. Active surveillance to determine the impact of methicillin resistance on mortality in patients with bacteremia and influences of the use of antibiotics on the development of MRSA infection.
    Porto JP; Santos RO; Gontijo Filho PP; Ribas RM
    Rev Soc Bras Med Trop; 2013; 46(6):713-8. PubMed ID: 24474012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS).
    Gastmeier P; Sohr D; Geffers C; Behnke M; Daschner F; Rüden H
    Infection; 2005 Apr; 33(2):50-5. PubMed ID: 15827870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia.
    Wang FD; Chen YY; Chen TL; Liu CY
    Am J Infect Control; 2008 Mar; 36(2):118-22. PubMed ID: 18313513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus.
    Shurland S; Zhan M; Bradham DD; Roghmann MC
    Infect Control Hosp Epidemiol; 2007 Mar; 28(3):273-9. PubMed ID: 17326017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.
    Burton DC; Edwards JR; Horan TC; Jernigan JA; Fridkin SK
    JAMA; 2009 Feb; 301(7):727-36. PubMed ID: 19224749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between "classical" risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV MRSA strain.
    Vidal PM; Trindade PA; Garcia TO; Pacheco RL; Costa SF; Reinert C; Hiramatsu K; Mamizuka EM; Garcia CP; Levin AS
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):139-45. PubMed ID: 19146463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections.
    Oztoprak N; Cevik MA; Akinci E; Korkmaz M; Erbay A; Eren SS; Balaban N; Bodur H
    Am J Infect Control; 2006 Feb; 34(1):1-5. PubMed ID: 16443085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia.
    Huang SS; Yokoe DS; Hinrichsen VL; Spurchise LS; Datta R; Miroshnik I; Platt R
    Clin Infect Dis; 2006 Oct; 43(8):971-8. PubMed ID: 16983607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
    Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Molina J; Lopez-Medrano F; Ruiz E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MA; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
    Clin Microbiol Infect; 2013 Nov; 19(11):1049-57. PubMed ID: 23331461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.
    Cosgrove SE; Qi Y; Kaye KS; Harbarth S; Karchmer AW; Carmeli Y
    Infect Control Hosp Epidemiol; 2005 Feb; 26(2):166-74. PubMed ID: 15756888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methicillin-resistant Staphylococcus aureus bloodstream infection: risk factors and clinical outcome in non-intensive-care units.
    Naves KS; Vaz da Trindade N; Gontijo Filho PP
    Rev Soc Bras Med Trop; 2012; 45(2):189-93. PubMed ID: 22534990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
    Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
    Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
    Laupland KB; Ross T; Gregson DB
    J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.
    Melzer M; Eykyn SJ; Gransden WR; Chinn S
    Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USA300 methicillin-resistant Staphylococcus aureus emerging as a cause of bloodstream infections at military medical centers.
    Sherwood J; Park M; Robben P; Whitman T; Ellis MW
    Infect Control Hosp Epidemiol; 2013 Apr; 34(4):393-9. PubMed ID: 23466913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012.
    Simor AE; Pelude L; Golding G; Fernandes R; Bryce E; Frenette C; Gravel D; Katz K; McGeer A; Mulvey MR; Smith S; Weiss K;
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):390-7. PubMed ID: 26782274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: with investigation of the potential role of community-associated MRSA strains.
    Wang JT; Wang JL; Fang CT; Chie WC; Lai MS; Lauderdale TL; Weng CM; Chang SC
    J Infect; 2010 Dec; 61(6):449-57. PubMed ID: 20875455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in incidence of late-onset methicillin-resistant Staphylococcus aureus infection in neonatal intensive care units: data from the National Nosocomial Infections Surveillance System, 1995-2004.
    Lessa FC; Edwards JR; Fridkin SK; Tenover FC; Horan TC; Gorwitz RJ
    Pediatr Infect Dis J; 2009 Jul; 28(7):577-81. PubMed ID: 19478687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active surveillance to determine the impact of methicillin-resistant Staphylococcus aureus colonization on patients in intensive care units of a Veterans Affairs Medical Center.
    Patel M; Weinheimer JD; Waites KB; Baddley JW
    Infect Control Hosp Epidemiol; 2008 Jun; 29(6):503-9. PubMed ID: 18510459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.